BP Castrol Sanofi vaccine Deal Highlights Major Pharma and
The BP Castrol Sanofi vaccine deal illustrates Sanofi’s focus on expanding its role in global immunization while BP shifts away from non-core assets like
BP to Sell Majority Stake in Castrol Stake Sale to
BP's Castrol stake sale to Stonepeak Partners, valued at about $10.1 billion, is part of its strategic restructuring and portfolio refocus efforts.
BP Castrol stake sale: BP Nears Deal to Sell Majority Stake
BP Castrol stake sale is nearing completion, with BP expected to sell a majority stake to Stonepeak Partners as part of its strategic shift towards renewable